Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9CXC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,130
Award facts
- Contract value 100% obligated
- $32,130.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $32,130.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Kesimpta 20 mg/0.4 ml pen injectors. This non-competitive, non-set-aside contract was awarded on January 9, 2026, with an ultimate completion date of January 12, 2026, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Kesimpta is a specialty pharmaceutical product used in the treatment of multiple sclerosis, reflecting the Defense Logistics Agency Medical Supply Chain's ongoing requirement to provision specialized medications supporting military healthcare systems.
This delivery order is executed under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s broader Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999.99 million through December 2031). AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, leverages this comprehensive IDC vehicle to fulfill diverse pharmaceutical and medical supply requirements across military treatment facilities and government healthcare programs worldwide. The company's established federal contracting experience and capability to meet open competition requirements position it as a primary supplier for essential pharmaceutical commodities to the Department of Defense and related healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9CXC?
SPE2DR26F9CXC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F9CXC worth?
The government has obligated $32,130 on SPE2DR26F9CXC.
Is contract SPE2DR26F9CXC an order under another contract?
Yes. SPE2DR26F9CXC is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9CXC competed?
The extent of competition for SPE2DR26F9CXC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award